Evidence map›Paper›PMID 35127954›Full record

ReviewJournal of diabetes research2022

An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy.

Zunaira Qureshi, Murtaza Najabat Ali, Minahil Khalid

Open access · goldAbstract readReview
In one paragraph

Review in Journal of diabetes research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Diabetic Neuropathy: Pathophysiology Review.Current pain and headache reports · 2024
    Review
  12. Review
  13. Novel drugs affecting diabetic peripheral neuropathy.Iranian journal of basic medical sciences · 2024
    Review
  14. Neuroprotective Effects of Isolated Mangiferin fromCentral nervous system agents in medicinal chemistry · 2024
    Article
  15. Review
  16. Painful Diabetic Neuropathy: The Need for New Approaches.Journal of diabetes science and technology · 2024
    Review
  17. Review
  18. Review
  19. Review
  20. Diabetic neuropathy: Past, present, and future.Caspian journal of internal medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zunaira QureshiDepartment of Biomedical Engineering and Sciences, School of Mechanical and Manufacturing Engineering, National University of Sciences and Technology, H-12, 44000 Islamabad, Pakistan.ORCID https://orcid.org/0000-0003-1799-8113
Murtaza Najabat AliDepartment of Biomedical Engineering and Sciences, School of Mechanical and Manufacturing Engineering, National University of Sciences and Technology, H-12, 44000 Islamabad, Pakistan.ORCID https://orcid.org/0000-0002-3829-8215
Minahil KhalidDepartment of Biomedical Engineering and Sciences, School of Mechanical and Manufacturing Engineering, National University of Sciences and Technology, H-12, 44000 Islamabad, Pakistan.
National University of Sciences and Technology · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is the 4

Indexed as

AnalgesicsDiabetic NeuropathiesHumansPain ManagementQuality of LifeAnalgesics

Identifiers

PMID35127954
PMCPMC8813291
OpenAlexW4210640363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.